As members of Congress negotiate a bill focusing on driving down prescription drug costs, data from Open Secrets, a nonpartisan research group, shows that lobbying and ad spending from the pharmaceutical industry in 2022 surpassed $100 million last week.
Speaking at an event Monday in front of the Colorado Capitol, U.S. Sen. John Hickenlooper (D-CO) committed to fighting for health care equity, saying Congress has the responsibility to both expand health care coverage and lower costs.
Jared Polis approved the creation of a non-partisan review board with the power to set limits on the prices of expensive prescription drugs in Colorado.
On Friday, April 9 supporters of a Colorado bill that would create an independent board of experts to limit prescription drug prices gathered at the state Capitol building. The rally featured health care advocates and patients sharing their stories of having dealt with high prescription drug prices.
